propidium has been researched along with Benign Neoplasms, Brain in 12 studies
Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gliomas are the most common and devastating tumors of the central nervous system." | 5.35 | Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study. ( Battastini, AM; Bavaresco, L; Bernardi, A; Figueiró, F; Frozza, RL; Guterres, SS; Jäger, E; Pohlmann, AR; Salbego, C, 2008) |
| " Previous results with the preclinical GL261 glioblastoma (GB) showed that combination treatment of temozolomide (TMZ) + CX-4945 (protein kinase CK2 inhibitor) outperformed single treatments, provided an immune-friendly schedule was followed." | 4.02 | Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells. ( Arús, C; Candiota, AP; Martínez-Escardó, L; Villamañan, L; Yuste, VJ, 2021) |
| "Gliomas are the most common and devastating tumors of the central nervous system." | 1.35 | Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study. ( Battastini, AM; Bavaresco, L; Bernardi, A; Figueiró, F; Frozza, RL; Guterres, SS; Jäger, E; Pohlmann, AR; Salbego, C, 2008) |
| "Growth retardation of inoculated brain tumors and prolonged survival of inoculated rats were observed with treatment with the anticancer agents, except cisplatin." | 1.30 | Prediction of drug cytotoxicity in 9L rat brain tumor by using flow cytometry with a deoxyribonucleic acid-binding dye. ( Fujimoto, S; Iwadate, Y; Namba, H; Sueyoshi, K; Tagawa, M; Yamaura, A, 1997) |
| "Propidium iodide was employed for nuclear DNA staining." | 1.27 | Ploidy and proliferative activity of human brain tumors. A flow cytofluorometric study. ( Ascari, E; Butti, G; Danova, M; Gaetani, P; Knerich, R; Mazzini, G; Riccardi, A; Silvani, V; Ucci, G, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kadhim, ZA | 1 |
| Sulaiman, GM | 1 |
| Al-Shammari, AM | 1 |
| Khan, RA | 1 |
| Al Rugaie, O | 1 |
| Mohammed, HA | 1 |
| Villamañan, L | 1 |
| Martínez-Escardó, L | 1 |
| Arús, C | 1 |
| Yuste, VJ | 1 |
| Candiota, AP | 1 |
| Dilnawaz, F | 1 |
| Sahoo, SK | 1 |
| Vartholomatos, G | 1 |
| Alexiou, GA | 1 |
| Stefanaki, K | 1 |
| Lykoudis, EG | 1 |
| Tseka, G | 1 |
| Tzoufi, M | 1 |
| Sfakianos, G | 1 |
| Prodromou, N | 1 |
| Marzocco, S | 1 |
| Popolo, A | 1 |
| Bianco, G | 1 |
| Pinto, A | 1 |
| Autore, G | 1 |
| Mirbahai, L | 1 |
| Wilson, M | 1 |
| Shaw, CS | 1 |
| McConville, C | 1 |
| Malcomson, RD | 1 |
| Kauppinen, RA | 1 |
| Peet, AC | 1 |
| Chen, GG | 1 |
| Sin, FL | 1 |
| Leung, BC | 1 |
| Ng, HK | 1 |
| Poon, WS | 1 |
| Krajcí, D | 1 |
| Mares, V | 1 |
| Lisá, V | 1 |
| Bottone, MG | 1 |
| Pellicciari, C | 1 |
| Bernardi, A | 1 |
| Frozza, RL | 1 |
| Jäger, E | 1 |
| Figueiró, F | 1 |
| Bavaresco, L | 1 |
| Salbego, C | 1 |
| Pohlmann, AR | 1 |
| Guterres, SS | 1 |
| Battastini, AM | 1 |
| Wang, J | 1 |
| Basu, HS | 1 |
| Hu, L | 1 |
| Feuerstein, BG | 1 |
| Nederlof, PM | 1 |
| Deen, DF | 1 |
| Iwadate, Y | 1 |
| Fujimoto, S | 1 |
| Sueyoshi, K | 1 |
| Namba, H | 1 |
| Tagawa, M | 1 |
| Yamaura, A | 1 |
| Danova, M | 1 |
| Riccardi, A | 1 |
| Mazzini, G | 1 |
| Ucci, G | 1 |
| Gaetani, P | 1 |
| Silvani, V | 1 |
| Knerich, R | 1 |
| Butti, G | 1 |
| Ascari, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Topical Application of 5% Imiquimod, 0.05% Imiquimod and 0.05% Nanoencapsulated Imiquimod Gel in the Treatment of Actinic Cheilitis: a Randomized Controlled Trial[NCT04219358] | Phase 1 | 49 participants (Actual) | Interventional | 2019-03-23 | Terminated (stopped due to Study terminated because of COVID19 pandemics.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 other studies available for propidium and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
Topics: Acridine Orange; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Chick Embryo; Em | 2022 |
Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Prot | 2021 |
Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model.
Topics: Acridine Orange; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cu | 2013 |
The value of cell cycle analysis by propidium-iodine staining of CD56+ cells in pediatric brain tumors.
Topics: Adolescent; Brain Neoplasms; CD56 Antigen; Cell Cycle; Cell Division; Child; Child, Preschool; DNA, | 2015 |
Pro-apoptotic effect of methylguanidine on hydrogen peroxide-treated rat glioma cell line.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Br | 2010 |
Lipid biomarkers of glioma cell growth arrest and cell death detected by 1 H magic angle spinning MRS.
Topics: Animals; Annexin A5; Biomarkers, Tumor; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; C | 2012 |
Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
Topics: Annexin A5; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Brain | 2005 |
Intranuclear microtubules are hallmarks of an unusual form of cell death in cisplatin-treated C6 glioma cells.
Topics: Actin Cytoskeleton; Annexin A5; Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Death; Cell | 2006 |
Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Brain Neoplasms; Cell Count | 2008 |
Radiation-induced changes in nucleoid halo diameters of aerobic and hypoxic SF-126 human brain tumor cells.
Topics: Aerobiosis; Brain; Brain Neoplasms; Cell Hypoxia; Cell Survival; DNA Damage; DNA, Neoplasm; DNA, Sup | 1995 |
Prediction of drug cytotoxicity in 9L rat brain tumor by using flow cytometry with a deoxyribonucleic acid-binding dye.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; DNA, Neoplasm; Drug Resistance, Neoplasm | 1997 |
Ploidy and proliferative activity of human brain tumors. A flow cytofluorometric study.
Topics: Adolescent; Adult; Aged; Aneuploidy; Brain Neoplasms; DNA, Neoplasm; Evaluation Studies as Topic; Fe | 1987 |